GR3034447T3 - Lectin domain variants of selectin. - Google Patents

Lectin domain variants of selectin.

Info

Publication number
GR3034447T3
GR3034447T3 GR20000402139T GR20000402139T GR3034447T3 GR 3034447 T3 GR3034447 T3 GR 3034447T3 GR 20000402139 T GR20000402139 T GR 20000402139T GR 20000402139 T GR20000402139 T GR 20000402139T GR 3034447 T3 GR3034447 T3 GR 3034447T3
Authority
GR
Greece
Prior art keywords
selectin
lectin domain
variants
amino acid
nucleotide sequences
Prior art date
Application number
GR20000402139T
Other languages
English (en)
Inventor
David V Erbe
Laurence A Lasky
Leonard G Presta
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of GR3034447T3 publication Critical patent/GR3034447T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Volatile Memory (AREA)
  • Semiconductor Memories (AREA)
GR20000402139T 1992-04-30 2000-09-20 Lectin domain variants of selectin. GR3034447T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87903692A 1992-04-30 1992-04-30
US95670192A 1992-10-01 1992-10-01
PCT/US1993/003987 WO1993022436A1 (en) 1992-04-30 1993-04-28 Lectin domain variants of selectin

Publications (1)

Publication Number Publication Date
GR3034447T3 true GR3034447T3 (en) 2000-12-29

Family

ID=27128518

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402139T GR3034447T3 (en) 1992-04-30 2000-09-20 Lectin domain variants of selectin.

Country Status (12)

Country Link
US (1) US5593882A (el)
EP (1) EP0639224B1 (el)
JP (2) JPH07506253A (el)
AT (1) ATE194168T1 (el)
AU (1) AU674317B2 (el)
CA (1) CA2134756C (el)
DE (1) DE69328928T2 (el)
DK (1) DK0639224T3 (el)
ES (1) ES2152251T3 (el)
GR (1) GR3034447T3 (el)
PT (1) PT639224E (el)
WO (1) WO1993022436A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0753065B1 (en) 1994-03-29 2003-05-14 Celltech Therapeutics Limited Antibodies against e-selectin
US6127524A (en) * 1996-10-18 2000-10-03 Dade Behring Inc. Binding molecules and computer-based methods of increasing the binding affinity thereof
BR0110963A (pt) * 2000-05-19 2003-11-25 Inst Genetics Llc Estruturas cristalinas e tridimensionais de lectina e semelhante a egf (le) de p-lectina
EP1842551A1 (en) * 2000-05-24 2007-10-10 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services E-selectin for treating or preventing stroke
US7897575B2 (en) * 2000-05-24 2011-03-01 The United States Of America As Represented By The Department Of Health And Human Services Treatment and prevention of vascular dementia
BR0116138A (pt) 2000-12-13 2003-09-23 Borean Pharma As Bibliotecas combinatóriais de proteìnas tendo a estrutura de andaime de domìnios tipo lectina tipo c
EP2284270A3 (en) 2000-12-13 2012-07-25 Anaphore, Inc. Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
DE60235348D1 (de) * 2001-02-20 2010-04-01 Summit Glycores Corp Lectine zur analyse von zuckerketten und verfahren zu ihrer verwendung
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
AU2002359815A1 (en) * 2001-12-19 2003-07-09 Immunex Corporation C-type lectin polypeptide, polynucleotide and methods of making and use thereof
US20070244043A1 (en) * 2005-03-10 2007-10-18 Novavax, Inc. Recombinant E-selectin made in insect cells
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
EP2662091B1 (en) 2006-12-01 2018-08-22 Selexys Pharmaceuticals Corporation Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
JP2010538655A (ja) * 2007-09-12 2010-12-16 アナフォア インコーポレイテッド 自己免疫疾患についてのｈｓｐ７０に基づく治療
CA2777162A1 (en) * 2009-10-09 2011-04-14 Anaphore, Inc. Polypeptides that bind il-23r
US20110086806A1 (en) * 2009-10-09 2011-04-14 Anaphore, Inc. Polypeptides that Bind IL-23R
EP2654781B1 (en) * 2010-12-21 2018-01-24 Selexys Pharmaceuticals Corporation Anti-p-selectin antibodies and methods of their use and identification
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
EP3601321A1 (en) * 2017-03-29 2020-02-05 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Purification of an agent of interest

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081034A (en) * 1988-11-14 1992-01-14 Brigham & Women's Hospital Cloned genes which encode elam-1
US5098833A (en) * 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor
CA2086323C (en) * 1990-07-17 2002-05-14 Rodger P. Mcever Functionally active selectin-derived peptides and ligand for gmp-140

Also Published As

Publication number Publication date
JP2004049234A (ja) 2004-02-19
JPH07506253A (ja) 1995-07-13
DE69328928T2 (de) 2000-11-30
US5593882A (en) 1997-01-14
ATE194168T1 (de) 2000-07-15
AU674317B2 (en) 1996-12-19
EP0639224B1 (en) 2000-06-28
AU4220893A (en) 1993-11-29
CA2134756A1 (en) 1993-11-11
DK0639224T3 (da) 2000-10-30
WO1993022436A1 (en) 1993-11-11
DE69328928D1 (de) 2000-08-03
PT639224E (pt) 2000-12-29
EP0639224A1 (en) 1995-02-22
JP3749529B2 (ja) 2006-03-01
CA2134756C (en) 2010-04-20
ES2152251T3 (es) 2001-02-01

Similar Documents

Publication Publication Date Title
GR3034447T3 (en) Lectin domain variants of selectin.
AU7261994A (en) Hydrazino-type radionuclide chelators having an n3s configuration
DE69232537D1 (de) Rezeptoren der steroid/thyroid superfamilie von rezeptoren
HK1016018A1 (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
AU7528894A (en) Hydrazino-type n2s2 chelators
UA42760C2 (uk) Спосіб спрямування клітинної імунної відповіді проти віл-інфікованої клітини ссавця,білковий мембранозв'язаний химерний рецептор,днк,яка кодує химерний рецептор,вектор,що її містить
TR199900267T2 (xx) GnRH-L�kotoksin kimeralar�.
ZA946770B (en) Hybrid toxin
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
WO2000005367A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
DE69434384D1 (de) Metalkomplexbildner
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
MXPA00002111A (es) Biomoleculas que contienen un peptido elastomerico.
EP1279677A4 (en) GD3 MIMETIC PEPTIDES
DE69619808D1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
EP0972054A4 (en) INCREASING IMMUNE RESPONSE USING TARGETED MOLECULES
IL156041A0 (en) Nucleic acid adjuvants
HK1011924A1 (en) Monoclonal antibodies to antigens expressed by hematopoietic facilitaroy cells.
DK0676965T3 (da) Fremgangsmåde til at reducere immunogeniciteten af variable regioner på antistoffer
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
WO2000000506A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins